Sort
11,323 grants matching “glioblastoma”
T CELL FOCUSED CANCER VACCINES IN MURINE TUMOR MODELS
$102,604Providence Portland Medical Center · R29 · FY2001 · CA
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
$102,364Forest M White · Massachusetts Institute Of Technology · U54 · FY2019 · CA
Development of Mouse Astrocytoma Model for Preclinical Testing
$102,353Karlyne M Reilly · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Use of CTEP portfolio compounds to counteract phenotype conversion in GBM
$102,267Frank Pajonk · University Of California Los Angeles · R01 · FY2024 · CA
Immune Monitoring and Biospecimen Core
$102,178Joanna Phillips · University Of California, San Francisco · U19 · FY2021 · CA
Development of Nuclear Auger Emitters for Targeted Radiotherapy
$101,904Thomas Reiner · Sloan-Kettering Inst Can Research · R21 · FY2015 · CA
Integrative Cancer Genomics: Drivers, Pathways and Drugs
$101,640Dana Pe'er · Columbia Univ New York Morningside · R01 · FY2014 · CA
UCLA IRB # 06-04-016 "PHASE II TRIAL OF BEVACIZUMAB IN COMBINATION WITH TEMOZ
$101,598Timothy Cloughesy · University Of California Los Angeles · M01 · FY2008 · RR
Administrative Core
$101,519David M. Ashley · Duke University · U19 · FY2025 · CA
MITOGENIC NEUROPEPTIDE RECEPTORS IN BRAIN TUMORS
$101,500St. Jude Children'S Research Hospital · R29 · FY2000 · CA
Neuropathology Core
$100,928David N Louis · Dana-Farber Cancer Inst · P01 · FY2008 · CA
Analysis of active and inactive EGFR conformations
$100,809Kathryn M Ferguson · University Of Pennsylvania · R01 · FY2015 · CA
Steady states and cellular transitions associated with carcinogenesis and tumor progression
$100,749James R. Heath · California Institute Of Technology · U01 · FY2017 · CA
Determination of Musashi1/CD44v6 signaling in mesenchymal glioma stem cells
$100,748Ichiro Nakano · Ohio State University · R21 · FY2015 · CA
Evolutionary Heterogeneity of High Grade Glioma
$100,662Erik Ladewig · Sloan-Kettering Inst Can Research · K00 · FY2021 · CA
Cell-Free DNA Methylation Patterns as a Biomarker for Tumor Biology and Clinical Outcomes for Glioblastoma Patients
$100,586Eugene Vaios · Duke University · K38 · FY2024 · CA
Cell-Free DNA Methylation Patterns as a Biomarker for Tumor Biology and Clinical Outcomes for Glioblastoma Patients
$100,526Eugene Vaios · Duke University · K38 · FY2025 · CA
11 Solid Tumor Therapeutics Program
$100,450Timothy J Eberlein · Washington University · P30 · FY2022 · CA
11 Solid Tumor Therapeutics Program
$100,450Timothy J Eberlein · Washington University · P30 · FY2024 · CA
11 Solid Tumor Therapeutics Program
$100,450Timothy J Eberlein · Washington University · P30 · FY2023 · CA
Alternative Splicing Rewiring by Neurofibromin Isoforms Through ER-alpha and RAS Dependent Mechanisms
$100,416Patrick Dischinger · Henry Ford Health + Michigan State University Health Sciences · K00 · FY2025 · CA
Perturbation based single cell investigation of tumor micro-environment
$100,360Chi Zhang · Dana-Farber Cancer Inst · K00 · FY2024 · CA
Sex Differences in Blood-Brain and Blood-Tumor Barrier Dynamics in Glioblastoma
$100,270Samuel Adam Tyler Sprowls · University Of Pittsburgh At Pittsburgh · K00 · FY2024 · CA
Novel therapeutic approach in treatment of glioblastoma using sustained delivery of Connxin43 carboxy-terminal peptide encapsulated in biodegradable nanoparticles in combination with temozolomide
$100,000Christina Grek · Xequel Bio, Inc. · R44 · FY2020 · CA
METVAN: A Novel Anticancer Agent
$100,000Paradigm Pharmaceuticals, Llc · R43 · FY2003 · CA